Daniel Aghion - 05 Jun 2025 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Director
Signature
/s/ Daniel Aghion
Issuer symbol
ORMP
Transactions as of
05 Jun 2025
Transactions value $
$0
Form type
4
Filing time
09 Jun 2025, 16:08:22 UTC
Previous filing
30 Jan 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Aghion Daniel Director 1185 AVENUE OF THE AMERICAS, NEW YORK /s/ Daniel Aghion 09 Jun 2025 0002004805

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +30K +77.28% 68.8K 05 Jun 2025 Direct F1
transaction ORMP Common Stock Award +8.37K +12.16% 77.2K 05 Jun 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 . Represents Restricted Stock Units ("RSUs") that will vest in equal portions of 10,000 as follows: January 1, 2026, January 1, 2027 and January 1, 2028. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
F2 Represents RSUs that will vest in equal installments as follows: on grant, July 1, 2025, October 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.